Publication|Articles|October 6, 2025
Supplements and Featured Publications
- The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment
The Role of TEVIMBRA® (tislelizumab-jsgr) in First-Line ESCC Treatment
Advertisement
This Clinical Brief was sponsored by BeOne Medicines.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
3
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
4
How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA
5